Open Access Gold möglich sobald Verlagsversion bei der ZB eingereicht worden ist.
Transplantation of human islets without immunosuppression.
Proc. Natl. Acad. Sci. U.S.A. 110, 19054-19058 (2013)
Transplantation of pancreatic islets is emerging as a successful treatment for type-1 diabetes. Its current stringent restriction to patients with critical metabolic lability is justified by the long-term need for immunosuppression and a persistent shortage of donor organs. We developed an oxygenated chamber system composed of immune-isolating alginate and polymembrane covers that allows for survival and function of islets without immunosuppression. A patient with type-1 diabetes received a transplanted chamber and was followed for 10 mo. Persistent graft function in this chamber system was demonstrated, with regulated insulin secretion and preservation of islet morphology and function without any immunosuppressive therapy. This approach may allow for future widespread application of cell-based therapies.
Impact Factor
Scopus SNIP
Scopus
Cited By
Cited By
Altmetric
0.000
2.641
173
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Immune Barrier ; Oxygenation ; β-cell Replacement
Sprache
englisch
Veröffentlichungsjahr
2013
HGF-Berichtsjahr
0
ISSN (print) / ISBN
0027-8424
e-ISSN
1091-6490
Quellenangaben
Band: 110,
Heft: 47,
Seiten: 19054-19058
Verlag
National Academy of Sciences
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Pancreatic Islet Research (IPI)
PubMed ID
24167261
Erfassungsdatum
2013-12-31